Cargando…
Immune correlates in a Phase II clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancer
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646127/ http://dx.doi.org/10.1186/2051-1426-3-S2-P106 |
| _version_ | 1782400920607260672 |
|---|---|
| author | Subudhi, Sumit K Aparicio, Ana Gao, Jianjun Zurita, Amado John, Araujo Logothetis, Christopher Rao, Brinda Vence, Luis Allison, James Emerson, Ryan O Yusko, Erik Vignali, Marissa Robins, Harlan Sun, Jing Jing Sharma, Padmanee |
| author_facet | Subudhi, Sumit K Aparicio, Ana Gao, Jianjun Zurita, Amado John, Araujo Logothetis, Christopher Rao, Brinda Vence, Luis Allison, James Emerson, Ryan O Yusko, Erik Vignali, Marissa Robins, Harlan Sun, Jing Jing Sharma, Padmanee |
| author_sort | Subudhi, Sumit K |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4646127 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46461272015-11-20 Immune correlates in a Phase II clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancer Subudhi, Sumit K Aparicio, Ana Gao, Jianjun Zurita, Amado John, Araujo Logothetis, Christopher Rao, Brinda Vence, Luis Allison, James Emerson, Ryan O Yusko, Erik Vignali, Marissa Robins, Harlan Sun, Jing Jing Sharma, Padmanee J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4646127/ http://dx.doi.org/10.1186/2051-1426-3-S2-P106 Text en Copyright © 2015 Subudhi et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Subudhi, Sumit K Aparicio, Ana Gao, Jianjun Zurita, Amado John, Araujo Logothetis, Christopher Rao, Brinda Vence, Luis Allison, James Emerson, Ryan O Yusko, Erik Vignali, Marissa Robins, Harlan Sun, Jing Jing Sharma, Padmanee Immune correlates in a Phase II clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancer |
| title | Immune correlates in a Phase II clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancer |
| title_full | Immune correlates in a Phase II clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancer |
| title_fullStr | Immune correlates in a Phase II clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancer |
| title_full_unstemmed | Immune correlates in a Phase II clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancer |
| title_short | Immune correlates in a Phase II clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancer |
| title_sort | immune correlates in a phase ii clinical trial with ipilimumab in combination with finite androgen deprivation therapy in patients with metastatic non-castrate prostate cancer |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4646127/ http://dx.doi.org/10.1186/2051-1426-3-S2-P106 |
| work_keys_str_mv | AT subudhisumitk immunecorrelatesinaphaseiiclinicaltrialwithipilimumabincombinationwithfiniteandrogendeprivationtherapyinpatientswithmetastaticnoncastrateprostatecancer AT aparicioana immunecorrelatesinaphaseiiclinicaltrialwithipilimumabincombinationwithfiniteandrogendeprivationtherapyinpatientswithmetastaticnoncastrateprostatecancer AT gaojianjun immunecorrelatesinaphaseiiclinicaltrialwithipilimumabincombinationwithfiniteandrogendeprivationtherapyinpatientswithmetastaticnoncastrateprostatecancer AT zuritaamado immunecorrelatesinaphaseiiclinicaltrialwithipilimumabincombinationwithfiniteandrogendeprivationtherapyinpatientswithmetastaticnoncastrateprostatecancer AT johnaraujo immunecorrelatesinaphaseiiclinicaltrialwithipilimumabincombinationwithfiniteandrogendeprivationtherapyinpatientswithmetastaticnoncastrateprostatecancer AT logothetischristopher immunecorrelatesinaphaseiiclinicaltrialwithipilimumabincombinationwithfiniteandrogendeprivationtherapyinpatientswithmetastaticnoncastrateprostatecancer AT raobrinda immunecorrelatesinaphaseiiclinicaltrialwithipilimumabincombinationwithfiniteandrogendeprivationtherapyinpatientswithmetastaticnoncastrateprostatecancer AT venceluis immunecorrelatesinaphaseiiclinicaltrialwithipilimumabincombinationwithfiniteandrogendeprivationtherapyinpatientswithmetastaticnoncastrateprostatecancer AT allisonjames immunecorrelatesinaphaseiiclinicaltrialwithipilimumabincombinationwithfiniteandrogendeprivationtherapyinpatientswithmetastaticnoncastrateprostatecancer AT emersonryano immunecorrelatesinaphaseiiclinicaltrialwithipilimumabincombinationwithfiniteandrogendeprivationtherapyinpatientswithmetastaticnoncastrateprostatecancer AT yuskoerik immunecorrelatesinaphaseiiclinicaltrialwithipilimumabincombinationwithfiniteandrogendeprivationtherapyinpatientswithmetastaticnoncastrateprostatecancer AT vignalimarissa immunecorrelatesinaphaseiiclinicaltrialwithipilimumabincombinationwithfiniteandrogendeprivationtherapyinpatientswithmetastaticnoncastrateprostatecancer AT robinsharlan immunecorrelatesinaphaseiiclinicaltrialwithipilimumabincombinationwithfiniteandrogendeprivationtherapyinpatientswithmetastaticnoncastrateprostatecancer AT sunjingjing immunecorrelatesinaphaseiiclinicaltrialwithipilimumabincombinationwithfiniteandrogendeprivationtherapyinpatientswithmetastaticnoncastrateprostatecancer AT sharmapadmanee immunecorrelatesinaphaseiiclinicaltrialwithipilimumabincombinationwithfiniteandrogendeprivationtherapyinpatientswithmetastaticnoncastrateprostatecancer |